Health Care Reform

The groups filing the lawsuit noted that 17 states and Puerto Rico have passed laws requiring insurance plans to count manufacturer copay assistance toward patients' out-of-pocket obligations.

Matt Eyles is leaving his CEO post in October after leading AHIP through the COVID-19 pandemic and helping to enact the No Surprises Act legislation, as the association conducts a search for his replacement.

A more aggressive Federal Trade Commission is starting to target drug mergers and industry middlemen – pharmacy benefit managers, as part of Biden's push for lower drug prices.

As part of the plan, people with traditional Medicare who take insulin will not pay more than $35 for a month's supply beginning July 1.

The recommendation is a huge win for the pharmaceutical company, likely paving the way for the company's first-of-its-kind gene therapy for treat Duchenne muscular dystrophy, a deadly disease.

The insurance market is much more complex and therefore requires more thought, introspection, and strategy when it comes to selecting the optimal plan. As the landscape changes, here are three things that brokers need to do now